Where cellular science becomes commercial reality

Polymor Biotech develops pharmaceutical-grade PDRN polynucleotide oral delivery systems built on clinically validated mechanisms. Our growing pipeline of proprietary complexes is available for licensing to established brands worldwide.

We do not sell supplements. We build the science behind them.

Every complex in our pipeline begins with a mechanism that has years of published clinical research behind it. We engineer the oral delivery system, assemble the cofactor stack, file patent protection, and offer the result exclusively via licensing. Our partners bring the brand, the distribution, and the market relationship. We bring the IP.

The global market for evidence-backed, mechanism-driven supplements is growing rapidly. Consumers and practitioners are no longer satisfied with category convention. They want defensible science, pharmaceutical-grade sourcing, and formulations that can withstand scrutiny. That is what Polymor delivers.